ArticleTherapeutics and clinical risk management2019

Calcium and vitamin D supplementation with 3-year denosumab treatment is beneficial to enhance bone mineral density in postmenopausal patients with osteoporosis and rheumatoid arthritis.

Takako Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.